Clinical and Microbiological Profile of Melioidosis in a Tertiary Care Hospital in Kerala, India

Divya Vijayakumar Department of Microbiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Divya Vijayakumar in
Current site
Google Scholar
PubMed
Close
,
Hridya Vikraman Department of Microbiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Hridya Vikraman in
Current site
Google Scholar
PubMed
Close
,
Poornima Baby Department of Microbiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Poornima Baby in
Current site
Google Scholar
PubMed
Close
,
Dipu Sathyapalan Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Dipu Sathyapalan in
Current site
Google Scholar
PubMed
Close
,
Amritavarshini Sreekumar Center for Nanoscience and Molecular Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Amritavarshini Sreekumar in
Current site
Google Scholar
PubMed
Close
,
Abitha Abdulla Department of Microbiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Abitha Abdulla in
Current site
Google Scholar
PubMed
Close
,
Athira Santhosh Center for Nanoscience and Molecular Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Athira Santhosh in
Current site
Google Scholar
PubMed
Close
,
Gautham Sreekumar Center for Nanoscience and Molecular Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Gautham Sreekumar in
Current site
Google Scholar
PubMed
Close
,
Lalitha Biswas Center for Nanoscience and Molecular Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Lalitha Biswas in
Current site
Google Scholar
PubMed
Close
,
Haritha Subhagan Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Haritha Subhagan in
Current site
Google Scholar
PubMed
Close
,
Chiranjay Mukhopadhyay Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India;

Search for other papers by Chiranjay Mukhopadhyay in
Current site
Google Scholar
PubMed
Close
,
Harpreet Kaur Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India

Search for other papers by Harpreet Kaur in
Current site
Google Scholar
PubMed
Close
,
Mohammed Ashiq Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India;

Search for other papers by Mohammed Ashiq in
Current site
Google Scholar
PubMed
Close
,
Raja Biswas Center for Nanoscience and Molecular Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Raja Biswas in
Current site
Google Scholar
PubMed
Close
, and
Anil Kumar Department of Microbiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India;

Search for other papers by Anil Kumar in
Current site
Google Scholar
PubMed
Close
Restricted access

ABSTRACT.

Melioidosis is a neglected tropical infection caused by the Gram-negative bacterium Burkholderia pseudomallei, which is found in soil and water across tropical countries. The infection spectrum ranges from mild localized lesions to severe sepsis. The clinical presentation, severity, and outcome are influenced by the route of infection, bacterial load, strain virulence, and specific virulence genes of B. pseudomallei. This case series discusses nine melioidosis cases, highlighting the clinical and diagnostic challenges. It underscores the necessity for a high level of clinical suspicion to ensure a timely diagnosis and the prompt initiation of treatment.

Author Notes

Financial support: This study was funded by the Indian Council of Medical Research “MISSION Task Force project” (Ref. no: ECD/NTF/20/2022-23).

Disclosure: This study was approved by the institutional ethics committee (IEC-AIMS-2022-MICRO-118). Informed consent was obtained for all participants. The authors have no conflicts of interest.

Current contact information: Divya Vijayakumar, Hridya Vikraman, Poornima Baby, Dipu Sathyapalan, Abitha Abdulla, Haritha Subhagan, and Anil Kumar, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India, E-mails: divarchives@gmail.com, hridyakv1996@gmail.com, poornimasankar0709@gmail.com, diputsmck@gmail.com, abithaabdulla02@gmail.com, drharitha05mmc@gmail.com, and vanilkumar@aims.amrita.edu. Amritavarshini Sreekumar, Athira Santhosh, Lalitha Biswas, and Raja Biswas, Center for Nanoscience and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, India, E-mails: amritavarshinisnambiar@gmail.com, athirakadampanattu98@gmail.com, lalithabiswas@aims.amrita.edu, and rajabiswas@aims.amrita.edu. Gautham Sreekumar, Pattathil Veedu, Kollam, India, E-mail: sr.gautham07@gmail.com. Chiranjay Mukhopadhyay and Mohammed Ashiq, Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India, E-mails: chiranjay.m@manipal.edu and drmohammedashiqs@gmail.com. Harpreet Kaur, Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family, Welfare, New Delhi, E-mail: kaurh.hq@icmr.gov.in.

Address correspondence to Anil Kumar, Microbiology, Amrita Institute of Medical Sciences, Kochi, Kerala 682041, India. E-mail: vanilkumar@aims.amrita.edu
  • 1.

    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), 2012. Possession, use, and transfer of select agents and toxins; biennial review. Final rule. Fed Regis 77: 6108361115.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Melioidosis.info Raising Awareness of Melioidosis. Available at: https://www.melioidosis.info. Accessed September 20, 2024.

    • PubMed
    • Export Citation
  • 3.

    Zimmermann RE, Ribolzi O, Pierret A, Rattanavong S, Robinson MT, Newton PN, Davong V, Auda Y, Zopfi J, Dance DAB, 2018. Rivers as carriers and potential sentinels for Burkholderia pseudomallei in Laos. Sci Rep 8: 8674.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Wiersinga WJ, Currie BJ, Peacock SJ, 2012. Melioidosis. N Engl J Med 367: 10351044.

  • 5.

    National Centre for Disease Control (NCDC) CD Alert: Melioidosis, April 2019. Available at: https://ncdc.mohfw.gov.in/wp-content/uploads/2024/05/meliodosis-cd_alert-duly-launched-by-hon_ble-hfm-on-annual-day-on-30th-july-2019.pdf. Accessed December 21, 2024.

    • PubMed
    • Export Citation
  • 6.

    Merritt AJ, Peck M, Gayle D, Levy A, Ler Y-H, Raby E, Gibbs TM, Inglis TJJ, 2016. Cutaneous melioidosis cluster caused by contaminated wound irrigation fluid. Emerg Infect Dis 22: 14201427.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Meumann EM et al., 2006. Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol 44: 30283030.

  • 8.

    Wongtrakoongate P, Mongkoldhumrongkul N, Chaijan S, Kamchonwongpaisan S, Tungpradabkul S, 2007. Comparative proteomic profiles and the potential markers between Burkholderia pseudomallei and Burkholderia thailandensis. Mol Cell Probes 21: 8191.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    European Committee on Antimicrobial Susceptibility Testing, European Society of Clinical Microbiology and Infectious Diseases Clinical Breakpoints and Dosing of Antibiotics. Available at: https://www.eucast.org/clinical_breakpoints. Accessed December 21, 2024.

    • PubMed
    • Export Citation
  • 10.

    Chowdhury S et al., 2022. The epidemiology of melioidosis and its asssociation with diabetes mellitus: A systematic review and meta-analysis. Pathogens 11: 149.

  • 11.

    Shetty AK, Boloor R, Sharma V, Bhat GHK, 2010. Melioidosis and pulmonary tuberculosis co-infection in a diabetic. Ann Thorac Med 5: 113115.

  • 12.

    Veluthat C, Venkatnarayan K, Padaki P, Krishnaswamy UM, 2021. Case of melioidosis misdiagnosed as pulmonary tuberculosis. BMJ Case Rep 14: e242499.

  • 13.

    Yadav V, Pawar A, Meena M, Khadanga S, Gupta A, Dandasena TP, Singhai A, Joshi R, Saigal S, Atlani M, 2023. Melioidosis as a mystique infection: A study from Central India. Cureus 15: e43439.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Gupta N, Bhat SN, Reddysetti S, Kadavigere R, Godkhindi VM, Mukhopadhyay C, Saravu K, 2021. Osteoarticular melioidosis: A retrospective cohort study of a neglected disease. Infez Med 29: 574582. PMID: 35146367

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Foong YW, Tan NW, Chong CY, Thoon KC, Tee NW, Koh MJ, 2015. Melioidosis in children: A retrospective study. Int J Dermatol 54: 929938.

  • 16.

    Hemarajata P, Baghdadi JD, Hoffman R, Humphries RM, 2016. Burkholderia pseudomallei: Challenges for the clinical microbiology laboratory. J Clin Microbiol 54: 28662873.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Mohapatra PR, Mishra B, 2022. Burden of melioidosis in India and South Asia: Challenges and ways forward. Lancet Reg Health Southeast Asia 2: 100004.

  • 18.

    Dance D, 2014. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents 43: 310318.

  • 19.

    Tiangpitayakorn C, Songsivilai S, Piyasangthong N, Dharakul T, 1997. Speed of detection of Burkholderia pseudomallei in blood cultures and its correlation with the clinical outcome. Am J Trop Med Hyg 57: 9699.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Currie BJ, Jacups SP, 2003. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 9: 15381542.

  • 21.

    Mukhopadhyay C, Shaw T, Varghese GM, Dance DAB, 2018. Melioidosis in South Asia. Trop Med Infect Dis. 3: 51.

    • PubMed
    • Export Citation
  • 22.

    Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB, Limmathurotsakul D, 2018. Melioidosis. Nat Rev Dis Primers 4: 17107.

  • 23.

    Sarovich DS, Webb JR, Pitman MC, Viberg LT, Mayo M, Baird RW, Robson JM, Currie BJ, Price EP, 2018. Raising the stakes: Loss of efflux pump regulation decreases meropenem susceptibility in Burkholderia pseudomallei. Clin Infect Dis 67: 243250.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Hii SYF et al., 2023. Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015–2018 and the genomic characterization of β-lactam-resistant isolates. Antimicrob Agents Chemother 95: e0223020.

    • PubMed
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 32130 32130 30784
Full Text Views 37 37 22
PDF Downloads 20 20 7
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save